RBC Life Sciences, Inc.

$0.00+0.00%(+$0.00)
TickerSpark Score
72/100
Solid
100
Valuation
60
Profitability
40
Growth
60
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RBCL research report →

52-Week Range100% of range
Low $0.00
Current $0.00
High $0.00

Companywww.rbclifesciences.com

RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements.

CEO
David Price
IPO
2000
Employees
89
HQ
Irving, TX, US

Price Chart

+600.00% · this period
$0.00$0.00$0.00May 19Nov 17May 19

Valuation

Market Cap
$1.55K
P/E
-0.00
P/S
0.00
P/B
0.00
EV/EBITDA
5.84
Div Yield
0.00%

Profitability

Gross Margin
52.82%
Op Margin
-2.59%
Net Margin
-2.93%
ROE
-10.08%
ROIC
-8.78%

Growth & Income

Revenue
$25.77M · 5.78%
Net Income
$-756,284 · -1.95%
EPS
$-0.34 · 0.00%
Op Income
$-666,283
FCF YoY
100.15%

Performance & Tape

52W High
$0.00
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-12.32
Avg Volume
158

Get TickerSpark's AI analysis on RBCL

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Dec 11, 12TYSINGER CYNTHIA Lother1,800

Our RBCL Coverage

We haven't published any research on RBCL yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate RBCL Report →

Similar Companies